These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17079140)

  • 41. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors.
    Aronov AM; Baker C; Bemis GW; Cao J; Chen G; Ford PJ; Germann UA; Green J; Hale MR; Jacobs M; Janetka JW; Maltais F; Martinez-Botella G; Namchuk MN; Straub J; Tang Q; Xie X
    J Med Chem; 2007 Mar; 50(6):1280-7. PubMed ID: 17300186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
    Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
    J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists.
    Jorand-Lebrun C; Brondyk B; Lin J; Magar S; Murray R; Reddy A; Shroff H; Wands G; Weiser W; Xu Q; McKenna S; Brugger N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2080-5. PubMed ID: 17321742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
    Mewshaw RE; Bowen SM; Harris HA; Xu ZB; Manas ES; Cohn ST
    Bioorg Med Chem Lett; 2007 Feb; 17(4):902-6. PubMed ID: 17188490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs).
    Miller CP; Bhaket P; Muthukaman N; Lyttle CR; Shomali M; Gallacher K; Slocum C; Hattersley G
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7516-20. PubMed ID: 21036041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
    Pinto DJ; Orwat MJ; Koch S; Rossi KA; Alexander RS; Smallwood A; Wong PC; Rendina AR; Luettgen JM; Knabb RM; He K; Xin B; Wexler RR; Lam PY
    J Med Chem; 2007 Nov; 50(22):5339-56. PubMed ID: 17914785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.
    Li HY; McMillen WT; Heap CR; McCann DJ; Yan L; Campbell RM; Mundla SR; King CH; Dierks EA; Anderson BD; Britt KS; Huss KL; Voss MD; Wang Y; Clawson DK; Yingling JM; Sawyer JS
    J Med Chem; 2008 Apr; 51(7):2302-6. PubMed ID: 18314943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity.
    Dow RL; Carpino PA; Hadcock JR; Black SC; Iredale PA; DaSilva-Jardine P; Schneider SR; Paight ES; Griffith DA; Scott DO; O'Connor RE; Nduaka CI
    J Med Chem; 2009 May; 52(9):2652-5. PubMed ID: 19351113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
    Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
    J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
    Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
    J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
    Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
    Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androstene-3,5-dienes as ER-beta selective SERMs.
    Blizzard TA; Gude C; Morgan JD; Chan W; Birzin ET; Mojena M; Tudela C; Chen F; Knecht K; Su Q; Kraker B; Mosley RT; Holmes MA; Rohrer SP; Hammond ML
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6295-8. PubMed ID: 17890084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
    Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG
    J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands.
    Lanter JC; Fiordeliso JJ; Allan GF; Musto A; Hahn do W; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5646-9. PubMed ID: 16942875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of inhibitors of protein kinase B using fragment-based lead discovery.
    Saxty G; Woodhead SJ; Berdini V; Davies TG; Verdonk ML; Wyatt PG; Boyle RG; Barford D; Downham R; Garrett MD; Carr RA
    J Med Chem; 2007 May; 50(10):2293-6. PubMed ID: 17451234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.
    Silvestri R; Cascio MG; La Regina G; Piscitelli F; Lavecchia A; Brizzi A; Pasquini S; Botta M; Novellino E; Di Marzo V; Corelli F
    J Med Chem; 2008 Mar; 51(6):1560-76. PubMed ID: 18293908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.